Elagolix Sodium

CHEMBL502182 Phase 4 ได้รับการอนุมัติ Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

653.6 g/mol

LogP

—

Phase

4

A salt form of elagolix, this medication reduces hormone levels that drive endometrial tissue growth, helping to relieve endometriosis-related pain. The sodium salt form supports its pharmaceutical formulation.

น้ำหนักโมเลกุล

653.6000 g/mol

TPSA

102.00 Å²

ด้านการรักษา

Endometriosis

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)[O-])c3ccccc3)c2=O)c1F.[Na+]

InChI

InChI=1S/C32H30F5N3O5.Na/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33;/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42);/q;+1/p-1/t25-;/m0./s1

Molecular Formula

C32H29F5N3NaO5

HBD / HBA

1 / 11

พันธะที่หมุนได้

12

อะตอมหนัก

46

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A salt form of elagolix, this medication reduces hormone levels that drive endometrial tissue growth, helping to relieve endometriosis-related pain. The sodium salt form supports its pharmaceutical formulation.

Yes, Elagolix Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL502182. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24785956. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

กำลังมองหาข้อมูลที่เข้าใจง่ายสำหรับผู้ป่วยอยู่ใช่ไหม?

Elagolix Sodium บน PillFYI

โครงสร้าง

ข้อมูลด่วน

สูตร: C32H29F5N3NaO5

ลิงก์ภายนอก

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.